- Deficit spending: Trump was bad, but Biden has been worse.
- Cause of inflation: Trump bears some blame, but again, Biden has been worse.
- “The Biden administration wants to throw a grenade into this carefully balanced ecosystem for research, development, and commercialization of a new medical technology.”
- We may be able to use CRISPR to treat rare inflammatory diseases.
Author: John C. Goodman
Friday Links
- “You can very clearly halve your children’s risk of schizophrenia through polygenic selection, which costs only a few hundred dollars if you’re already doing IVF…. In a decade or two you can probably eliminate the risk entirely.”
- Roughly 90 percent of Americans are effectively blocked from opening an HSA.
- How to create HSAs in the Obamacare Exchanges. (National Review)
- Americans who trust the government to do the right thing most of the time: 10% Elites: 79% Super Elites: 89%. Maybe that’s because the elites run the government.
- What the future holds for weight loss drugs. (Bloomberg)
- Have economists oversold the idea of “moral hazard”?
Thursday Links
- Prescription drug pricing: Most cost-effectiveness analyses exclude probable end-of-patent, life cycle pricing – and set the initial price too low.
- Private approaches may be the best answer to public health problems.
- Rep Michael Burgess on why the CBO needs to consider the long-term benefits of preventive medicine.
- Looks like there are more deaths by fire than by ice. But there are still more deaths by cold than by warming.
Wednesday Links
- How to get more kidney transplants without creating a market for kidneys.
- If new drugs can make it in America, they are developed. If they can’t, they aren’t.
- “A box of fruit or vegetables says ‘Produced in California’ or ‘Origin: Mexico,’ but you have no idea where a container of generic Tylenol came from or whether you can feel confident in the product.”
- Standing in the way of a cure for Parkinson’s disease: the FDA bureaucracy.